Sonic Healthcare Ltd
ASX:SHL
Intrinsic Value
Sonic Healthcare Ltd. engages in the provision of medical diagnostics services. [ Read More ]
The intrinsic value of one
SHL
stock under the Base Case scenario is
32.17
AUD.
Compared to the current market price of 26.74 AUD,
Sonic Healthcare Ltd
is
Undervalued by 17%.
Sonic Healthcare Ltd's market capitalization is 12.7B AUD.
SHL stock price is 26.74 AUD.
SHL stock price (26.74 AUD) is 17% less than its Intrinsic Value (32.17 AUD).
SHL stock price (26.74 AUD) is 39% less than its Relative Value (43.62 AUD). Open Relative Valuation
SHL has upside potential of 18% compared to the average analyst price target.
Open Wall St Estimates
SHL's Revenue has been growing by 2% per year for the last 3 years.
SHL has positive three-year average ROIC (Return on Invested Capital): 11%. The company is efficient at using invested capital to generate operating income.
SHL has positive Net Income for the last twelve months.
SHL's Revenue has dropped by 3% over the past 12 months.
SHL's ROE (Return on Equity) for the past 12 months is positive and is equal to 7%.
SHL's Altman Z-Score is equal to 2.58.
SHL's Revenue is forecast to grow at a rate of 6% per year over the next 3 years.
SHL's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 5%.
SHL's short-term liabilties (2B AUD) exceed its short-term assets (2B AUD).
SHL's ROIC (Return on Invested Capital) has decreased in the last 3 years from 11% to 5%.
SHL has positive Operating Income for the last twelve months.
SHL's ROE (Return on Equity) has significantly decreased in the last 3 years from 17% to 7%.
SHL has positive three-year average ROE (Return on Equity): 16%. The company is efficient at transforming stockholders' equity into net income.
SHL has positive Free Cash Flow for the last twelve months.
SHL's long-term assets (14B AUD) exceed its long-term liabilties (6B AUD).
SHL has positive Gross Profit for the last twelve months.
SHL's D/E (Debt to Equity) is very low and is equal to 0.41.
SHL has positive Net Debt. This means that the company has more debt (3B AUD) than cash and short-term investments (620m AUD).
SHL doesn't generate enough operating income (805m AUD) to safely cover interest payments on its debt (-105m AUD).
Valuation Backtest
Sonic Healthcare Ltd
Run backtest to discover the historical profit from buying and selling
SHL
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Sonic Healthcare Ltd
Balance Sheet Decomposition
Sonic Healthcare Ltd
| Current Assets | 2B |
| Cash & Short-Term Investments | 619.6m |
| Receivables | 1.1B |
| Other Current Assets | 345m |
| Non-Current Assets | 11.7B |
| Long-Term Investments | 170.7m |
| PP&E | 2.9B |
| Intangibles | 8.6B |
| Other Non-Current Assets | 108.1m |
| Current Liabilities | 2.2B |
| Accounts Payable | 857.5m |
| Other Current Liabilities | 1.3B |
| Non-Current Liabilities | 3.9B |
| Long-Term Debt | 3.2B |
| Other Non-Current Liabilities | 693.4m |
Earnings Waterfall
Sonic Healthcare Ltd
|
Revenue
|
8.4B
AUD
|
|
Cost of Revenue
|
-1.3B
AUD
|
|
Gross Profit
|
7B
AUD
|
|
Operating Expenses
|
-6.2B
AUD
|
|
Operating Income
|
804.7m
AUD
|
|
Other Expenses
|
-299.7m
AUD
|
|
Net Income
|
504.9m
AUD
|
Free Cash Flow Analysis
Sonic Healthcare Ltd
SHL Profitability Score
Profitability Due Diligence
Sonic Healthcare Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Score
Sonic Healthcare Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
SHL Solvency Score
Solvency Due Diligence
Sonic Healthcare Ltd's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Score
Sonic Healthcare Ltd's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SHL Price Targets Summary
Sonic Healthcare Ltd
According to Wall Street analysts, the average 1-year price target for
SHL
is 31.48 AUD
with a low forecast of 26.21 AUD and a high forecast of 36.69 AUD.
Shareholder Return
SHL Price
Sonic Healthcare Ltd
| Average Annual Return | 10.28% |
| Standard Deviation of Annual Returns | 32.36% |
| Max Drawdown | -42% |
| Market Capitalization | 12.7B AUD |
| Shares Outstanding | 480 404 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Sonic Healthcare Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Sonic Healthcare Ltd. engages in the provision of medical diagnostics services. The company is headquartered in Macquarie, New South Wales and currently employs 38,000 full-time employees. The firm is engaged in the specialist operations in laboratory medicine / pathology, radiology, general practice medicine, and corporate medical services. The firm's segments include Laboratory, Radiology and Other. The Laboratory segment provides pathology/clinical laboratory services in Australia, New Zealand, the United Kingdom, the United States of America, Germany, Switzerland, and Belgium. The Radiology segment provides diagnostic imaging services in Australia. The Other segment includes medical center operations (IPN), occupational health services (Sonic HealthPlus), and other minor operations. Sonic Clinical Services (SCS) is the primary care division of the Company, which provides a range of health services. The firm's services are provided to medical practitioners, hospitals, community health services, and their collective patients. The firm has more than 100 radiology centers.
Contact
IPO
Employees
Officers
The intrinsic value of one
SHL
stock under the Base Case scenario is
32.17
AUD.
Compared to the current market price of 26.74 AUD,
Sonic Healthcare Ltd
is
Undervalued by 17%.
You don't have any saved screeners yet
